Specify a stock or a cryptocurrency in the search bar to get a summary
Karolinska Development AB ser. B
KDEVKarolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden. Address: Nanna Svartz väg 6A, Solna, Sweden, 17165
Analytics
WallStreet Target Price
48.9 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures KDEV
Dividend Analytics KDEV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History KDEV
Stock Valuation KDEV
Financials KDEV
Results | 2019 | Dynamics |